来自MSN1 天
AZN, Daiichi's ADC Gets FDA Breakthrough Tag for EGFR-Mutated NSCLC
AstraZeneca AZN and its Japanese partner Daiichi Sankyo announced that the FDA has granted a Breakthrough Therapy designation ...
HUTCHMED: ORPATHYS And TAGRISSO Get Breakthrough Therapy Designation In China For NSCLC
Limited (HCM) announced that the Center for Drug Evaluation of Chinas National Medical Products Administration or ...
研究亚裔美国人肺癌趋势的华裔教授，自己却成为了病例
数十年来肺癌罹患机率整体下降，但不曾抽烟的亚裔美国人得肺癌机率却越来越高; 示意图。（图/123RF） 雅虎生活新闻（Yahoo Life）27日报导，专门研究亚裔美国人未抽烟却得肺癌趋势的斯坦福大学（Stanford ...
Medscape9 天
Epidermal Growth Factor Receptor as a Target in Pancreatic Cancer
The phosphorylation of protein kinases leads to the activation of signal-transduction pathways, which have a critical role in a variety of biologic processes, including cell growth ...
The Taipei Times2 天
4% of patients not covered for NHI EGFR-mutated lung cancer drugs: doctors
Among Taiwan’s non-small cell lung cancer cases, approximately 55 percent involve an EGFR mutation, with deletion of exon 19 and exon 21 the most common mutations, treatable with first to ...
The Pharma Letter2 天
First ‘Breakthrough’ designation for datopotamab deruxtecan
Datopotamab deruxtecan (Dato-DXd) has been granted Breakthrough Therapy designation (BTD) by the US Food and Drug ...
Rare NRG1 Fusion Therapeutics Market Size in the 7MM was ~USD 37 million in 2023, estimated ...
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Rare NRG1 Fusion Therapeutics ...
Pharmabiz2 天
US FDA grants breakthrough therapy designation to datopotamab deruxtecan for patients with ...
US FDA grants breakthrough therapy designation to datopotamab deruxtecan for patients with previously treated advanced EGFR-mutated NSCLC: Cambridge, UK Tuesday, December 10, 2024 ...